1 |
Nam GE, Kim YH, Han KD, Jung JH, Rhee EJ, Lee WY. Obesity fact sheet in Korea, 2020: prevalence of obesity by obesity class from 2009 to 2018. J Obes Metab Syndr. 2021 ; 30(2) : 141-2.
DOI
|
2 |
Srivastava G, Apovian C. Future pharmacotherapy for obesity: new anti-obesity drugs on the horizon. Current Obesity Reports. 2018 ; 7(2) : 147-61.
DOI
|
3 |
KIOM. Obesity Korean medicine clinical practice guideline. Seoul : Elsevier Korea. 2016 : 84.
|
4 |
The Co-textbook Publishing Committee of Korean Oriental Medicine School. Herbal medicine. Seoul : Younglimsa. 2016 : 153.
|
5 |
Hwang MJ, Shin HD, Song MY. Review of literature on herbal medicines for the treatment of obesity in Korea: mainly papers since 2000. J Oriental Rehab Med. 2006 ; 16(3) : 65-81.
|
6 |
Shannon JR, Gottesdiener K, Jordan J, Chen K, Flattery S, Larson PJ, et al. Acute effect of ephedrine on 24-h energy balance. Clinical Science. 1999 ; 96(5) : 483-91.
DOI
|
7 |
Jang IS, Yang CS, Hwang EH. The need for clinical practice guidelines in usage of Mahuang in weight loss. J Korean Med Obes Res. 2007 ; 7(1) : 23-9.
|
8 |
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011.
|
9 |
Persky AM, Berry NS, Pollack GM, Brouwer KL. Modelling the cardiovascular effects of ephedrine. Br J Clin Pharmacol. 2004 ; 57(5) : 552-62.
DOI
|
10 |
Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. International Journal of Obesity. 2001 ; 25(3) : 316-24.
DOI
|
11 |
Kim HJ, Han CH, Lee EJ, Song YK, Shin BC, Kim YK. A clinical practice guideline for Ma-huang (Ephedra sinica) prescription in obesity. J Korean Med Obes Res. 2007 ; 7(2) : 27-37.
|
12 |
Drew CD, Knight GT, Hughes DT, Bush M. Comparison of the effects of D-(-)-ephedrine and L-(+)-pseudoephedrine on the cardiovascular and respiratory systems in man. Br J Clin Pharmacol. 1978 ; 6(3) : 221-5.
DOI
|
13 |
Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. International Journal of Obesity. 2002 ; 26(5) : 593-604.
DOI
|
14 |
Hsing LC, Lee TH, Son DH, Yeo JJ, Yang CS, Seo ES, et al. Adverse effects of Ma-huang according to dose: a randomized double-blind placebo-controlled pilot study. Korean J Orient Int Med. 2006 ; 27(1) : 188-96.
|
15 |
Palamar J. How ephedrine escaped regulation in the United States: a historical review of misuse and associated policy. Health Policy. 2011 ; 99(1) : 1-9.
DOI
|
16 |
Greenway F L, D e Jonge L, B lanchard D , F risard M , Smith SR. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition. Obesity Research. 2004 ; 12(7) : 1152-7.
DOI
|
17 |
Samenuk D, Link MS, Homoud MK, Contreras R, Theohardes TC, Wang PJ, et al. Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine. Mayo Clin Proc. 2002 ; 77(1) : 12-6.
DOI
|
18 |
Kim HJ, Park JM, Kim JA, Ko BP. Effect of herbal Ephedra sinica and Evodia rutaecarpa on body composition and resting metabolic rate: a randomized, double- blind clinical trial in Korean premenopausal women. J Acupunct Meridian Stud. 2008 ; 1(2) : 128-38.
DOI
|
19 |
Jo GW, Ok JM, Kim SY, Lim YW. Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT. J Korean Med. 2017 ; 38(3) : 170-84.
DOI
|
20 |
Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, et al. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial. International Journal of Obesity. 2006 ; 30(10) : 1545-56.
DOI
|
21 |
Coffey CS, Steiner D, Baker BA, Allison DB. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. International Journal of Obesity. 2004 ; 28(11) : 1411-9.
DOI
|